查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999360

體外震波碎石術市場：依技術、應用、最終用戶、便攜性和治療模式分類－2026-2032年全球市場預測

Extracorporeal Shock Wave Lithotripsy Market by Technology, Application, End User, Portability, Treatment Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，體外震波碎石術 (ESWL) 市值將達到 3.8292 億美元，到 2026 年將成長至 4.1024 億美元，到 2032 年將達到 6.0268 億美元，年複合成長率為 6.69%。

主要市場統計數據
基準年 2025 3.8292億美元
預計年份：2026年 4.1024億美元
預測年份 2032 6.0268億美元
複合年成長率 (%) 6.69%

策略實施概述，概述了影響現代體外震波碎石術 (ESWL) 採用的臨床效用、工作流程影響和決策標準。

體外震波碎石術（ESWL）作為一種非侵入性治療方法，在現代泌尿系統中發揮核心作用，用於擊碎膽管和泌尿道結石。其臨床意義在於，它能夠利用聚焦聲能擊碎結石，同時最大限度地減少手術創傷，從而加快患者康復並有效利用醫療資源。近年來，隨著影像技術、衝擊波發生技術以及設備人體工學改進的進步，ESWL已從一種純粹的院內手術發展成為一種高度靈活的治療選擇，廣泛應用於門診手術中心和診所。

技術進步、分散式治療模式與臨床路徑最佳化如何影響體外震波碎石術的現況？

體外震波碎石術（ESWL）領域正經歷一場變革，其驅動力來自技術、臨床和操作等多面向因素的共同作用。衝擊波發生技術的創新，例如電解法、電磁法和壓電法，正在最佳化能量傳遞和設備耐用性；而整合成像和即時回饋技術的進步則提高了靶點定位精度和臨床療效。同時，設備便攜性的提升模糊了固定式醫院系統和適用於門診環境的行動治療單元之間的界限，催生了新的醫療服務模式，並擴大了社區醫療中心的覆蓋範圍。

新關稅趨勢對體外震波碎石術 (ESWL) 生態系統的供應鏈策略、採購慣例和總成本的影響。

2025年關稅的實施為醫療設備生態系統帶來了新的挑戰，包括供應鏈韌性、籌資策略和產品定價等問題。體外震波碎石術（ESWL）相關人員正透過營運和商業手段相結合的方式來應對這些壓力。面對進口零件成本的增加，製造商探索了多種方案，例如關鍵子組件的垂直整合、策略性庫存以及製造地的地域多元化，以降低風險。同時，服務提供者也審查了備件庫存和維護契約，以確保運作，同時避免將過高的成本轉嫁給臨床客戶。

詳細的細分分析揭示了技術類型、臨床應用、使用者環境、便攜性和治療模式如何決定產品定位和部署路徑。

細分市場分析突顯了技術選擇、臨床應用、使用者環境、便攜性要求和治療模式等方面的關鍵差異，這些差異共同影響著產品設計和市場進入策略。電液、電磁和壓電系統之間的技術選擇不僅影響聚焦精度和能量分散等臨床性能特徵，還影響可維護性、運行噪音和資本投資趨勢。這些差異指南醫院系統、門診手術中心和診所在決策過程中，根據手術量和醫療目標來選擇合適的設備功能。

區域監管差異、醫療基礎設施成熟度和服務網路如何影響體外震波碎石術 (ESWL) 技術的部署策略？

區域趨勢受制於不同的法規環境、醫療基礎設施和支付體系，這些因素影響技術的採取路徑和競爭策略。在美洲，先進臨床中心的集中分佈和廣泛的門診手術中心網路催生了對兼具性能和可維護性的設備的需求。同時，報銷政策和資本投資週期影響技術的採用時機。清晰的監管政策和成熟的技術服務生態系統為下一代系統的應用提供了支持，醫療服務提供者也日益尋求能夠簡化患者診療流程和文件記錄的整合解決方案。

競爭和服務生態系統分析表明，設備差異化、臨床夥伴關係和售後服務如何決定市場定位和採購結果。

體外震波碎石術（ESWL）產業格局複雜，老字型大小企業，也有創新新晉參與企業和專業服務供應商，各方都在臨床療效、設備可靠性和售後服務方面展開競爭。主要製造商持續致力於透過改進衝擊波發生技術和整合成像功能來實現產品差異化，同時增加對培訓和技術支援的投入，以減輕臨床團隊的營運負擔。新晉參與企業和小型供應商則專注於細分市場，例如可攜式系統和針對門診及診所環境最佳化的具成本效益機型，並力求透過極具吸引力的整體價值提案來改變現有的採購模式。

為製造商和供應商提供切實可行的優先建議，以調整產品設計、服務模式和證據生成，從而滿足多樣化的臨床和區域需求。

產業領導企業應採取多管齊下的策略，將技術開發、經營模式和臨床醫生協作相結合，以掌握體外震波碎石術 (ESWL) 領域的新機會。首先，應優先考慮設備的模組化和互通性，以便在不更換整個系統的情況下，透過不斷升級來適應不斷發展的成像和目標擷取功能。這可以減少醫院和診所客戶在整個生命週期中的中斷，並促進長期合作關係。其次，應設計能反映終端使用者多樣性的定價和服務方案，包括門診手術中心、多專科診所、泌尿系統診所以及公立和私立醫院。具體而言，可以透過提供擴充性的合約來實現這一點，這些合約既適用於獨立式和醫院安裝的門診設備，也適用於固定式高通量系統。

我們採用透明的混合方法研究途徑，結合臨床文獻、監管分析、技術審查和相關人員訪談，得出基於證據的策略見解。

本分析的研究結合了近期同行評審的臨床文獻、監管文件和產品技術文檔，並結合對臨床專家、採購經理和醫療設備工程師的結構化訪談。調查方法強調三角驗證，將領域專家的定性見解與設備規格和服務記錄進行交叉比對，以檢驗對技術性能、維護概況和臨床工作流程的解讀準確可靠。此外，還檢視了區域監管指南和公共報銷框架，以明確市場准入考量因素並識別實際應用障礙。

簡要概述了技術進步、營運重點和當地情況與擴大體外震波碎石術應用範圍的策略挑戰之間的連結。

總之，體外震波碎石術（ESWL）仍然是非侵入性碎石治療中一項至關重要的技術，其未來發展方向將受到技術進步、分散式醫療模式和切實可行的商業策略的影響。電液、電磁和壓電系統的進步，以及影像整合和便攜性的提升，正在拓展安全有效實施ESWL的可能性。同時，門診流程設計、可維護性和供應鏈韌性等營運需求正在影響採購決策，並塑造競爭優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：體外震波碎石術市場：依技術分類

  • 電液式
  • 電磁
  • 壓電

第9章：體外震波碎石市場：依應用領域分類

  • 膽結石
  • 腎結石
  • 輸尿管結石

第10章：體外震波碎石市場：依最終用戶分類

  • 門診手術中心
    • 獨立設施
    • 醫院設施
  • 診所
    • 全科診所
    • 泌尿系統診所
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 體外震波碎石市場：攜帶式

  • 移動的
  • 固定式

第12章 體外震波碎石術市場依治療方法分類

  • 住院治療
  • 門診

第13章 體外震波碎石市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 體外震波碎石市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 體外震波碎石術市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國體外震波碎石市場

第17章：中國體外震波碎石市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Beijing Well Medical Technology Co., Ltd.
  • Chongqing Haifu Ultrasound Technology Co., Ltd.
  • Dornier MedTech GmbH
  • EDAP TMS SA
  • EMS Electro Medical Systems SA
  • Medstone International Urology Pvt. Ltd.
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Storz Medical AG
Product Code: MRR-3A2E844FE771

The Extracorporeal Shock Wave Lithotripsy Market was valued at USD 382.92 million in 2025 and is projected to grow to USD 410.24 million in 2026, with a CAGR of 6.69%, reaching USD 602.68 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 382.92 million
Estimated Year [2026] USD 410.24 million
Forecast Year [2032] USD 602.68 million
CAGR (%) 6.69%

A strategic introductory overview that frames clinical utility, workflow implications, and decision criteria shaping contemporary extracorporeal shock wave lithotripsy adoption

Extracorporeal shock wave lithotripsy (ESWL) occupies a central role in contemporary urological care as a noninvasive modality for fragmenting calculi across the biliary and urinary tracts. Its clinical relevance is rooted in the ability to deliver focused acoustic energy to disrupt stones while minimizing surgical trauma, enabling faster recovery and reduced hospital resource utilization. Over recent years, ESWL has evolved from a purely hospital-based intervention to a versatile therapeutic option used across ambulatory surgical centers and clinics, supported by improvements in imaging, shock wave generation, and device ergonomics.

Clinicians and administrators alike are evaluating ESWL not only through clinical efficacy but also through workflow integration, patient throughput, and reimbursement dynamics. Technological refinements have improved stone localization and energy delivery, and these enhancements have accelerated adoption in settings beyond traditional inpatient units. Consequently, strategic decision-makers are balancing clinical outcomes, capital allocation, and operational considerations as they determine the role of ESWL within urology service lines.

This introduction establishes the clinical and operational context for stakeholders assessing the ESWL landscape. It lays the groundwork for sections that follow, which examine transformational shifts, tariff implications, segmentation insights, regional dynamics, competitive positioning, and practical recommendations for industry leaders seeking to position products and services for sustainable growth and clinical impact.

How converging technological refinements, decentralized delivery models, and clinical pathway optimization are reshaping the extracorporeal shock wave lithotripsy landscape

The ESWL landscape is undergoing transformative shifts driven by converging technological, clinical, and operational forces. Innovations in shock wave generation-spanning electrohydraulic, electromagnetic, and piezoelectric approaches-are optimizing energy delivery and device longevity, while advances in integrated imaging and real-time feedback are improving targeting accuracy and clinical outcomes. Parallel developments in portability have blurred the lines between stationary, hospital-based systems and mobile units suited to ambulatory environments, thereby enabling new care delivery models and extending access to community-based centers.

Clinical pathways are also evolving, with greater emphasis on outpatient treatment models and protocols that reduce inpatient burden. Ambulatory surgical centers, including both freestanding and hospital-based centers, are increasingly positioned to deliver ESWL safely and efficiently, and multispecialty clinics as well as urology-focused clinics are exploring service expansions. These shifts are accompanied by refinements in perioperative care and patient selection that enhance patient satisfaction and lower overall system costs.

Concurrently, regulatory scrutiny and device lifecycle management are prompting manufacturers to prioritize safety features, ease of use, and serviceability. Outcomes data and real-world evidence are being deployed to differentiate product value propositions, while collaborative models between clinicians, device makers, and payers are emerging to address reimbursement and access barriers. Taken together, these trends signal a transition toward more patient-centric, decentralized, and technology-driven ESWL care paradigms.

Impacts of new tariff dynamics on supply chain strategies, procurement practices, and total cost considerations within the extracorporeal shock wave lithotripsy ecosystem

The imposition of tariffs in 2025 introduced new considerations for supply chain resiliency, procurement strategy, and product pricing within the medical device ecosystem, and ESWL stakeholders are navigating these pressures with a mix of operational and commercial responses. Manufacturers faced with increased costs for imported components evaluated options including vertical integration of key subassemblies, strategic stockpiling, and selective geographic diversification of manufacturing footprints to mitigate exposure. In parallel, service organizations reexamined spare parts inventories and maintenance contracts to sustain uptime without passing disproportionate cost burdens to clinical customers.

Healthcare providers and purchasing groups reacted by intensifying scrutiny on total cost of ownership, prioritizing devices that offered longer service intervals, local technical support, and parts commonality across installed bases. As a result, procurement negotiations began to emphasize bundled service arrangements and outcome-based warranties that align maintenance incentives with device performance. For some market participants, tariffs accelerated conversations about nearshoring and partnerships with regional suppliers to stabilize supply chains and reduce lead times.

Importantly, these adaptations were complemented by increased investment in logistics visibility and risk modeling tools, which helped organizations anticipate disruptions and plan mitigations. While tariffs altered cost equations and contractual structures, they also prompted practical innovations in manufacturing strategy and supplier collaboration that can enhance long-term reliability and responsiveness across the ESWL value chain.

Detailed segmentation insights revealing how technology type, clinical application, user environment, portability, and treatment mode define product positioning and adoption pathways

Segment analysis highlights meaningful distinctions in technology preferences, clinical applications, user settings, portability requirements, and treatment modes that collectively shape product design and go-to-market strategies. Technology choice between electrohydraulic, electromagnetic, and piezoelectric systems influences not only clinical performance characteristics such as focal precision and energy dispersion but also serviceability, operating noise, and capital expenditure profiles. These differences guide decisions by hospital systems, ambulatory surgical centers, and clinics when aligning device capabilities with procedural volumes and care objectives.

Application segmentation between gallbladder stones, renal calculi, and ureteral calculi underscores divergent clinical requirements related to stone composition, size distribution, and anatomical access. Devices optimized for renal calculi may prioritize deeper focal penetration and adjustable energy profiles, while systems used for ureteral fragments require rapid targeting and integration with auxiliary imaging modalities. End-user diversity is significant: ambulatory surgical centers, both freestanding and hospital-based, emphasize throughput and rapid turnover; clinics, including multispecialty and urology clinics, prioritize ease of use and space efficiency; and hospitals, whether private or public, demand robust service support and regulatory compliance. Portability preferences split between mobile units that enable outreach and stationary systems that anchor high-volume centers, affecting installation requirements and marketing narratives.

Treatment mode considerations-namely inpatient versus outpatient pathways-further influence device feature sets, service contracts, and reimbursement interactions. Outpatient procedures prioritize streamlined patient flow and minimal anesthesia requirements, while inpatient settings focus on comprehensive perioperative integration and complex case capabilities. Taken together, these segmentation insights provide a nuanced framework for product positioning and commercial prioritization across stakeholder cohorts.

How regional regulatory variability, care infrastructure maturity, and service networks drive differentiated adoption strategies for extracorporeal shock wave lithotripsy technologies

Regional dynamics are shaped by diverse regulatory environments, care delivery infrastructures, and payer systems that affect adoption pathways and competitive strategies. In the Americas, a concentration of advanced clinical centers and extensive ambulatory surgical networks creates demand for devices that balance performance with serviceability, while reimbursement policies and capital procurement cycles influence adoption timing. Regulatory clarity and established technical service ecosystems support the introduction of next-generation systems, and providers increasingly seek integrated solutions that streamline patient throughput and documentation.

Across Europe, the Middle East & Africa, the landscape is heterogeneous: mature Western European systems emphasize evidence-based adoption and budgetary accountability, while emerging markets in the region prioritize cost-effective technologies and scalable service models. Regulatory frameworks vary, and market entrants benefit from localized clinical partnerships and adaptable commercial models that reflect payer diversity. In the Asia-Pacific region, rapid expansion of ambulatory capacity, investments in healthcare infrastructure, and growing clinical expertise are driving demand for both stationary high-throughput systems and mobile units that serve geographically dispersed populations. Local manufacturing partnerships and responsive after-sales networks play an outsized role in accelerating adoption and building clinician confidence.

Understanding these regional nuances is essential for companies seeking to tailor regulatory strategies, pricing approaches, and distribution models that align with local healthcare delivery and reimbursement realities. Transitioning from regional analysis to tactical planning, stakeholders should prioritize regulatory alignment, service network development, and clinician engagement to capture opportunities across varied markets.

Competitive and service ecosystem analysis showing how device differentiation, clinical partnerships, and after-sales support determine market positioning and procurement outcomes

Competitive dynamics in the ESWL sector reflect a mix of legacy incumbents, innovative entrants, and specialized service providers, each competing on clinical performance, device reliability, and after-sales support. Leading manufacturers maintain emphasis on product differentiation through advances in shock wave generation and imaging integration, while simultaneously investing in training and technical support that reduce operational friction for clinical teams. New entrants and smaller suppliers focus on niche opportunities, such as portable systems or cost-effective models tailored to ambulatory and clinic settings, seeking to disrupt established purchasing patterns with compelling total-value propositions.

Service organizations and third-party maintenance providers play a strategic role, particularly in regions where local technical capacity is limited. Partnerships between manufacturers and regional distributors are instrumental for scaling access and ensuring rapid parts availability, which in turn affects hospital and clinic preferences. Strategic collaborations between device makers and clinical champions are also shaping product roadmaps, with real-world evidence and clinician feedback driving iterative improvements in user interfaces, targeting accuracy, and patient comfort.

From a commercial perspective, differentiation increasingly hinges on demonstrable outcomes, ease of integration into existing workflows, and predictable lifecycle costs. Companies that can combine robust clinical evidence, responsive service networks, and adaptable financing or procurement models are best positioned to win procurement discussions and to expand installed bases across diverse care settings.

Practical and prioritized recommendations for manufacturers and providers to align product design, service models, and evidence generation with varied clinical and regional demands

Industry leaders should adopt a multi-pronged approach that aligns technology development, commercial models, and clinician engagement to capture emerging opportunities in ESWL. First, prioritize device modularity and interoperability so that systems can be upgraded with evolving imaging and targeting capabilities without requiring full replacement; this reduces total lifecycle disruption for hospital and clinic customers and supports long-term relationships. Second, design pricing and service bundles that reflect the diversity of end users-ambulatory surgical centers, multispecialty clinics, urology clinics, and both private and public hospitals-by offering scalable contracts that accommodate freestanding and hospital-based ambulatory units as well as stationary high-throughput systems.

Third, invest in regional service infrastructure and partnerships to shorten response times for maintenance and spare parts, which is particularly important in markets where local technical capacity is variable. Fourth, generate and disseminate robust real-world evidence across applications such as gallbladder stones, renal calculi, and ureteral calculi to support clinician adoption and reimbursement dialogues. Fifth, evaluate supply chain resilience measures-such as diversified sourcing and nearshoring-that mitigate tariff and logistics risks while maintaining quality standards. By sequencing these initiatives and aligning them with targeted regional strategies, companies can build durable competitive advantage and foster clinician trust.

Finally, foster clinician training programs and collaborative pilots that demonstrate operational efficiencies and patient outcomes; these initiatives not only accelerate adoption but also create advocates who help navigate institutional procurement processes and payer negotiations.

Transparent mixed-methods research approach combining clinical literature, regulatory analysis, technical review, and stakeholder interviews to produce evidence-based strategic insights

Research for this analysis combined a review of recent peer-reviewed clinical literature, regulatory filings, product technical documentation, and structured interviews with clinical specialists, procurement executives, and device engineers. The methodology emphasized triangulation: qualitative insights from domain experts were cross-validated with device specifications and service records to ensure robust interpretation of technology performance, maintenance profiles, and clinical workflows. Additionally, regional regulatory guidance and public reimbursement frameworks were examined to inform market access considerations and to identify practical barriers to adoption.

Primary research included discussions with clinicians across care settings-hospital inpatient units, ambulatory surgical centers both freestanding and hospital-based, multispecialty clinics, and specialized urology clinics-to capture diverse perspectives on device usability, patient selection, and integration into care pathways. Technical assessments considered differences across electrohydraulic, electromagnetic, and piezoelectric systems, as well as portability characteristics between mobile and stationary platforms. Supply chain and procurement perspectives were incorporated to reflect tariff impacts and logistics considerations.

Findings were synthesized into thematic insights that inform segmentation, regional dynamics, competitive positioning, and actionable recommendations. Throughout the research process, care was taken to separate clinical evidence from commercial assertions and to document assumptions underlying strategic implications.

Concise concluding synthesis linking technological evolution, operational priorities, and regional realities to the strategic imperatives for expanding extracorporeal shock wave lithotripsy access

In conclusion, extracorporeal shock wave lithotripsy remains a pivotal technology for noninvasive stone management, and its future trajectory will be shaped by technology refinement, decentralized care models, and pragmatic commercial strategies. Advances across electrohydraulic, electromagnetic, and piezoelectric systems, together with improvements in imaging integration and portability, are expanding the contexts in which ESWL can be delivered safely and effectively. Meanwhile, operational imperatives-such as outpatient pathway design, serviceability, and supply chain resilience-are influencing procurement decisions and shaping competitive differentiation.

Regional nuances underscore the importance of tailored approaches that reflect regulatory environments, payer structures, and local technical capabilities across the Americas, Europe Middle East & Africa, and Asia-Pacific markets. Competitive advantage will accrue to organizations that combine demonstrable clinical outcomes with reliable service networks and flexible commercial models that address the needs of ambulatory surgical centers, clinics, and hospitals. By translating clinical efficacy into predictable operational performance and manageable lifecycle costs, stakeholders can support broader access to ESWL while aligning product and service strategies with healthcare system priorities.

Ultimately, the path forward involves coordinated investments in technology, evidence generation, and regional partnerships that together enable scalable, patient-centered lithotripsy services across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Shock Wave Lithotripsy Market, by Technology

  • 8.1. Electrohydraulic
  • 8.2. Electromagnetic
  • 8.3. Piezoelectric

9. Extracorporeal Shock Wave Lithotripsy Market, by Application

  • 9.1. Gallbladder Stones
  • 9.2. Renal Calculi
  • 9.3. Ureteral Calculi

10. Extracorporeal Shock Wave Lithotripsy Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding Centers
    • 10.1.2. Hospital Based Centers
  • 10.2. Clinics
    • 10.2.1. Multispecialty Clinics
    • 10.2.2. Urology Clinics
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals

11. Extracorporeal Shock Wave Lithotripsy Market, by Portability

  • 11.1. Mobile
  • 11.2. Stationary

12. Extracorporeal Shock Wave Lithotripsy Market, by Treatment Mode

  • 12.1. Inpatient
  • 12.2. Outpatient

13. Extracorporeal Shock Wave Lithotripsy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Shock Wave Lithotripsy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Shock Wave Lithotripsy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Extracorporeal Shock Wave Lithotripsy Market

17. China Extracorporeal Shock Wave Lithotripsy Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Beijing Well Medical Technology Co., Ltd.
  • 18.6. Chongqing Haifu Ultrasound Technology Co., Ltd.
  • 18.7. Dornier MedTech GmbH
  • 18.8. EDAP TMS SA
  • 18.9. EMS Electro Medical Systems SA
  • 18.10. Medstone International Urology Pvt. Ltd.
  • 18.11. Olympus Corporation
  • 18.12. Richard Wolf GmbH
  • 18.13. Siemens Healthineers AG
  • 18.14. Storz Medical AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROHYDRAULIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY ELECTROMAGNETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PIEZOELECTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GALLBLADDER STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY RENAL CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY URETERAL CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY FREESTANDING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITAL BASED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MULTISPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 155. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 156. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 177. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 182. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 183. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 184. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 185. G7 EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 191. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 192. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 193. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 194. NATO EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY MARKET SIZE, BY TREATMENT MODE, 2018-2032 (USD MILLION)